Menu
About Us
Company Overview
Our Values
Board of Directors
Team
Scientific Advisers
Clinical Advisers
Corporate Directory
Corporate Governance
Pipeline
Clinical Trial
Investor Centre
Welcome
Investor Fact Sheet
ASX Announcements
Reports
Annual Reports
Half Yearly Reports
Quarterly Reports
Top 20 Shareholders
Research Reports
Shareholder Services
Investor FAQs
US Shareholders
Communication
In the News
Presentations
Posters
Publications
Contact Us
Contact Us
Email Alerts
Media
Recent Posts
Entitlement Offer to raise $4.27m
Proactive Interview with Dr Chris Burns
FDA clearance of Amplia's IND for pancreatic cancer trial in US
First patient dosed in phase 2a ACCENT trial
Investor Newsletter - December 2023
Approval from Korean regulator to initiate Phase 2 accent pancreatic cancer trial in Korea
Categories
Company News
Media
Uncategorized
Videos
13 Feb 2024
Proactive Interview with Dr Chris Burns
Read More
21 Nov 2023
AUSBIZ | Interview with Dr Chris Burns
Read More
22 May 2023
PROACTIVE INTERVIEW | Dr Chris Burns discusses Amplia's collaboration with CSIRO
Read More
19 Apr 2023
First Patient Recruited to Cohort 3 of ACCENT Trial in Pancreatic Cancer
Read More
06 Feb 2023
Channel 9 News | 3 February 2023
Read More
06 Feb 2023
The Courier Mail | New hope for advanced pancreatic cancer patients in clinical trials
Read More
06 Feb 2023
ABC Media Coverage | Pancreatic cancer clinical trial opens in Queensland, offering hope to patients
Read More
30 Jan 2023
PROACTIVE INTERVIEW | Dr Chris Burns
Read More
28 Sep 2022
Stockhead Investor Guide
Read More
18 Aug 2022
Channel 9 | Clinical Trial Recruitment
Read More
18 Aug 2022
The Australian | Drug to tear down tumour defences
Read More
18 Aug 2022
The Front Podcast | 18 August 2022
Read More
09 May 2022
ABC News | Bioshares
Read More
05 Apr 2022
New investment in pancreatic cancer research
Read More
11 Feb 2022
WOMEN IN SCIENCE | Rhiannon Jones, Director, Operations
Read More
01 Feb 2022
VIDEO | PROACTIVE Amplia Therapeutics readies for phase two clinical trials and "watershed year" for AMP945
Read More
30 Nov 2021
VIDEO | SMALL CAPS Amplia Therapeutics makes headway in anti-cancer clinical trial
Read More
18 Nov 2021
VIDEO | PROACTIVE Amplia Therapeutics details summary results from its phase 1 clinical trial of AMP945
Read More
10 Nov 2021
VIDEO | AUSBIZ Amplia's $12M plan; what's next for the Aussie medtech
Read More
21 Oct 2021
Switzer Daily | Therapeutics company primed for growth
Read More
1
2